Canada's Healwell AI Q2 revenue flat, swings to profit

Healwell Al

06/08/2026 21:49

Overview
Canada healthcare AI firm's Q2 revenue was flat yr/yr as project-based sales declined
Q2 net income from continuing operations improved to C$6.4 mln from a loss last year
Company plans to monetize C$23 mln SpaceX stake as lock-up expires

Outlook
Healwell continues to target an approximately 10% Adjusted EBITDA margin by year-end
Company intends to monetize SpaceX holding as lock-up expires to strengthen liquidity
Healwell sees a positive outlook for 2027 with margin improvement and recurring revenue growth

Result Drivers
REVENUE MIX SHIFT - Co said flat Q2 revenue reflected transition from episodic project-based sales to higher-margin, recurring enterprise sales
AI COMMERCIALIZATION - Co said it continues to commercialize its AI product suite, cross-selling SMART Search and SMART Summary into Orion Health's global customer base
OPERATING CASH FLOW IMPROVEMENT - Co said operating cash flow improved by C$14.3 mln yr/yr following Orion Health acquisition, reflecting increased efficiency

Company press release: ID:nNFC6xMSjB

Key Details
Metric
Beat/Miss
Actual
Consensus Estimate
Q2 Revenue
 
C$32.96 mln
 
Q2 Net Income
 
C$6.40 mln
 
Q2 Gross Profit
 
C$17.92 mln
 
Q2 Income From Operations
 
-C$6.18 mln
 
Q2 Operating Expenses
 
C$24.11 mln
 

Analyst Coverage
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 11 "strong buy" or "buy", no "hold" and no "sell" or "strong sell"
The average consensus recommendation for the advanced medical equipment & technology peer group is "buy"
Wall Street's median 12-month price target for Healwell Al Inc is C$2.50, about 267.6% above its August 5 closing price of C$0.68

Reuters Recommended Reads
Aug 6 - Privia Health Q2 revenue beats estimates, outlook raised
Aug 6 - Canada's Open Text Q4 revenue beats estimates on license, cloud growth
Aug 5 - SoundHound AI Q2 revenue jumps on enterprise AI deals, raises outlook

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)